What started off as basic research 25 years ago has now lead to a successfully approved drug: The entry blocker bulevirtide (brand name Hepcludex, formerly known as Myrcludex B), jointly developed by researchers...

Here is a look at some interesting infectious disease and health news reported across the globe: Ten health issues WHO will tackle this year The world is facing multiple health challenges. These range...